A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
Northport Veterans Affairs Medical Center Northport, New York, United States, 11768 Ogaki Municipal Hospital Ogaki-shi, Gifu, Japan, 503-8502 St Marianna University Hospital Kawasaki-shi, Kanagawa, Japan, 216-8511 Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center Yokohama-shi, Kanagawa, Japan, 241-8515 Shizuoka Cancer Center Sunto-gun, Shizuoka, Japan, 411-8777 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Seoul National University Hospital Seoul, Korea, Republic of, 03080 Severance Hospital Yonsei University Health System Seoul, Korea, Republic of, 03722 Asan Medical Center Seoul, Korea, Republic of, 05505 Samsung Medical Center Seoul, Korea, Republic of, 06351 National University Hospital Singapore, Singapore, 119074 National Taiwan University Hospital Taipei, Taiwan, 10002 Taipei Veterans General Hospital Taipei, Taiwan, 11217

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 7, 2023Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments